Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/512282]Researchers: Prof Mark Gorrell (Principal investigator)
Brief description We will further investigate the therapeutic potential of the Dipeptidyl Peptidase (DP) IV gene family by studying genes identified as probable therapeutic targets for stem cell transplant, anti-inflammatory and cancer therapies. DPIV is an identified target for diabetes therapy. Our research group is internationally recognised as expert in both liver disease pathogenesis and the DPIV gene family.
Funding Amount $AUD 478,067.91
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 512282
- PURL : https://purl.org/au-research/grants/nhmrc/512282
